SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech Valuation
An SI Board Since February 1999
Posts SubjectMarks Bans Symbol
51910 684 3 CRSP
Emcee:  Biomaven Type:  Moderated
Biotech stocks are a close second only to internet stocks in how difficult they are to objectively value. This means that biotech stocks can be wildly under- or over-valued, which creates an opportunity for either profit or frustration for an investor that "knows better than market." To paraphrase the master: "Every now and again you should look at the stock price to see if the market is offering to do anything stupid."

This thread grew out of the "Munch-a-Biotech" thread, and is meant to discuss biotech stock valuation methods of all sorts, as well as particular stocks or sectors you may feel are under- or over-valued.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
51910Am I correct in assuming that valuation modelers should expect asset values to gArt Bechhoefer1yesterday
51909I commented on the interest-rate effect in: twitter.com Valuation modelers are DewDiligence_on_SI-yesterday
51908There has been a gradual decline in prices of numerous small and medium size bioArt Bechhoefer-yesterday
51907XBI down to mid 90's. Wonder if the 2020 crash lows are out of the question.JamesK-Tuesday
51906Trying to find real kn95 and/or n95 masks? Here’s a summary of my adventure: 1software salesperson-last Saturday
51905Sorry to hear you were a victim Dew. You advised me a last June that PRTA (ProtLance Bredvold-January 12
51904For all practical purposes, in an indoor public environment one should assume thDewDiligence_on_SI3January 11
51903To your point smjerri, I should have added that the Asian empirical study didn&#A.J. Mullen-January 11
51902Certainly advection matters too. I recall an early empirical study done in eithA.J. Mullen-January 11
51901I'm glad they are finally doing this research and learning some of these spesjemmeri-January 11
51900Latest Covid Tracker from 1st Trust......................... COVID-19 Tracker (OldAIMGuy-January 11
51899Exact Sciences to buy Prevention Genetics and expand cancer screening capabilitiOldAIMGuy-January 11
51898In a room at a time of Covid, be most wary of those closest. Useful study lookinA.J. Mullen2January 11
51897Now I notice ILMN is up 14% on good results and an upgrade from Barclays. What&#A.J. Mullen-January 11
51896Pacific Biosciences is down 12% having posted results. Sales are up 65% in a yeA.J. Mullen-January 11
51895Holmes found guilty on four charges, not guilty on four, and no verdict on threeA.J. Mullen1January 3
51894GBS... GBS Inc. operates as a biosensor diagnostic technology company. It offersAloner-January 3
518932022 Biotech Charity Contest is running! Subject 60290technetium212/27/2021
51892Deloitte: Artificial intelligence technology investments prove top priority for Frank Sully-12/22/2021
51891This anti-Covid pill changes everything. So why won’t it be available for all? A.J. Mullen112/21/2021
51890$SIGY - Sigyn Therapeutics CEO Note: As Omicron Surges, Consider That the First Finlay Smith112/17/2021
51889Black Bird Biotech announced an independent testing lab, Botanical Research in MFinlay Smith-12/15/2021
51888CRISPR Therapeutics Is One of Today’s Best Biotech Value Investments Even as CRFrank Sully-12/10/2021
51887Intellia (NTLA) up 17%. I don't see any particular news on any of these. BArt Bechhoefer-12/7/2021
51886AI Hallucinates Novel Proteins Deep network dreams could greatly speed up desiFrank Sully112/7/2021
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):